PHARMACOECONOMICS

Scope & Guideline

Transforming health economics for a sustainable future.

Introduction

Immerse yourself in the scholarly insights of PHARMACOECONOMICS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1170-7690
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1992 to 2024
AbbreviationPHARMACOECONOMICS / Pharmacoeconomics
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The journal 'PHARMACOECONOMICS' focuses on the economic evaluation of health technologies, aiming to inform healthcare decision-making through rigorous analysis and modeling. It emphasizes the integration of clinical effectiveness with economic implications, encouraging a multidisciplinary approach that encompasses health policy, pharmacoeconomics, and public health.
  1. Economic Evaluation of Health Technologies:
    The journal publishes studies that evaluate the cost-effectiveness of various health interventions, including pharmaceuticals, medical devices, and healthcare services, using methodologies such as cost-utility analysis, cost-effectiveness analysis, and budget impact analysis.
  2. Modeling Approaches in Health Economics:
    A significant focus is on the development and application of various modeling techniques, including Markov models, discrete event simulation, and probabilistic modeling, to assess long-term outcomes and economic impacts of health interventions.
  3. Patient-Centered Outcomes and Quality of Life:
    Research related to the measurement of health-related quality of life (HRQoL) and patient preferences is prominent. This includes studies on utility measures like EQ-5D and their application in economic evaluations.
  4. Real-World Evidence and Data Utilization:
    The journal encourages the use of real-world data to inform economic evaluations and policy decisions, emphasizing the relevance of real-world evidence in assessing the economic impact of interventions.
  5. Interdisciplinary Approaches to Health Economics:
    It promotes an interdisciplinary perspective, integrating insights from clinical research, epidemiology, health policy, and behavioral economics to enhance the depth and applicability of economic evaluations.
The journal 'PHARMACOECONOMICS' is adapting to contemporary healthcare challenges and evolving research methodologies. Recent publications indicate a strong focus on innovative approaches and emerging themes in health economics.
  1. Value-Based Healthcare and Pricing Models:
    There is a growing emphasis on value-based healthcare frameworks that assess the value of interventions in terms of outcomes relative to costs. This trend reflects the shift towards outcome-oriented pricing models in the healthcare industry.
  2. Equity and Social Determinants of Health:
    Research addressing health equity and the social determinants of health is gaining traction, emphasizing the importance of considering how economic evaluations can impact diverse populations and promote equitable healthcare access.
  3. Integration of Real-World Data:
    The use of real-world data in economic evaluations is on the rise, highlighting the importance of incorporating actual patient outcomes and resource utilization into cost-effectiveness analyses.
  4. Patient and Stakeholder Engagement:
    There is an increasing focus on involving patients and stakeholders in the economic evaluation process to better capture preferences and improve the relevance of health technologies to end-users.
  5. Innovative Methodological Approaches:
    Emerging methodologies, such as machine learning and advanced statistical techniques, are being applied to economic evaluations, enhancing the robustness and precision of analyses in complex healthcare environments.

Declining or Waning

While the journal continues to thrive in various areas, certain themes have shown a decline in prominence over recent years. This shift may reflect changing priorities in health economics and emerging challenges in the healthcare landscape.
  1. Traditional Cost-Effectiveness Analysis:
    There is a noticeable reduction in studies solely focused on traditional cost-effectiveness analysis without considering broader implications, such as equity or long-term societal impacts. This indicates a shift towards more comprehensive evaluation frameworks.
  2. Pharmacoeconomic Evaluations of Older Therapies:
    Research on older therapies appears to be declining as newer, more innovative treatments emerge. The focus is shifting towards assessing the economic impact of cutting-edge therapies and technologies rather than established treatments.
  3. Narrowly Focused Economic Models:
    The journal has seen fewer publications that rely on narrowly focused economic models with limited scope. There is now a trend towards more complex models that account for a variety of factors, including patient heterogeneity and real-world complexities.
  4. Sole Emphasis on Cost Minimization:
    Papers that primarily focus on cost minimization strategies without addressing the broader implications for health outcomes and quality of life are becoming less frequent, as the field moves towards more holistic evaluations.
  5. Regional Studies with Limited Generalizability:
    There is a waning interest in studies that focus exclusively on localized economic evaluations without consideration for broader applicability or generalizability to other settings or populations.

Similar Journals

International Journal of Healthcare Management

Connecting scholars and practitioners in healthcare management.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2047-9700Frequency: 4 issues/year

The International Journal of Healthcare Management, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, stands as a crucial platform for the dissemination of innovative research and insights in the realm of healthcare management. With a focus on health policy, leadership, and management, this journal aims to bridge the gap between theory and practice, providing a valuable resource for researchers, professionals, and students alike. It boasts an impressive Q2 ranking in Leadership and Management and a Q3 ranking in Health Policy for 2023, highlighting its influence and relevance within the academic community. With an accessible ISSN of 2047-9700 and E-ISSN of 2047-9719, the journal features an array of peer-reviewed articles that promote the advancement of knowledge and best practices in healthcare settings. While currently not offered as open access, the journal publishes high-quality research that underscores the importance of effective management strategies in enhancing healthcare outcomes. Positioned in the United Kingdom, the journal continues to contribute significant knowledge and frameworks that guide healthcare leaders and policymakers in navigating the complexities of governance in health services.

HEALTH TECHNOLOGY ASSESSMENT

Fostering multidisciplinary approaches to health technology assessment.
Publisher: NIHR JOURNALS LIBRARYISSN: 1366-5278Frequency:

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Journal of the American College of Clinical Pharmacy

Empowering professionals through cutting-edge research.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

Journal of the National Comprehensive Cancer Network

Uniting Knowledge: A Premier Resource for Oncology Research and Practice
Publisher: HARBORSIDE PRESSISSN: 1540-1405Frequency: 15 issues/year

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

JOURNAL OF HEALTH ECONOMICS

Connecting Research and Policy for Enhanced Health Outcomes
Publisher: ELSEVIERISSN: 0167-6296Frequency: 6 issues/year

JOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.

Global & Regional Health Technology Assessment

Innovating health solutions through critical assessment.
Publisher: ABOUTSCIENCE SRLISSN: 2284-2403Frequency: 1 issue/year

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Empowering research that shapes the future of health technology.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0266-4623Frequency: 1 issue/year

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE is a leading academic journal published by Cambridge University Press, specializing in the critical evaluation of healthcare technologies and their impact on health policy. Established in 1970, it has gained recognition within the field, currently holding a prestigious Q2 ranking in Health Policy, with a commendable position of #89 out of 310 in the Scopus rankings, placing it in the 71st percentile. The journal serves as an essential platform for researchers, professionals, and students interested in the intersection of technology and health care, facilitating the dissemination of innovative research findings and practical assessments that inform policy-making and improve health outcomes. With a focus on advancing knowledge from 1985 to 2024, the journal's content remains relevant and impactful. Though not open access, it offers subscription-based access to a wealth of articles that contribute to shaping the future of healthcare technology assessment.

Pharmacoeconomics-Open

Bridging Knowledge Gaps in Pharmacoeconomics
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

ClinicoEconomics and Outcomes Research

Exploring the Intersection of Economics and Health Delivery
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6981Frequency: 1 issue/year

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

Journal of Health Economics and Outcomes Research

Advancing health policy through innovative research.
Publisher: COLUMBIA DATA ANALYTICS, LLCISSN: 2327-2236Frequency: 1 issue/year

Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.